Policy | August 16, 2021
India restricts export of Rapid Antigen Test Kits used to detect Covid 19
The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT
The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT
7.94 crore doses were made available to the states in May 2021
NATCO Pharmaceuticals, Hyderabad; Alembic Pharmaceuticals, Vadodara; Gufic Biosciences Ltd., Gujarat; Emcure Pharmaceuticals, Pune; and Lyka, Gujarat are new manufacturers
The government has taken all the effective measures to make healthcare affordable
Building upon the momentum gained by pharma sector during the pandemic, Indian Pharmaceutical Alliance is leaving no stone unturned to create a faster road to recovery.
Their feedback and the consequent changes in software/protocols based on those inputs were deliberated upon.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)